- Home
- AVBP vs INNV Comparison
AVBP vs INNV Comparison
Compare AVBP & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVBP
- INNV
- Stock Information
- Founded
- AVBP 2021
- INNV 2007
- Country
- AVBP United States
- INNV United States
- Employees
- AVBP N/A
- INNV N/A
- Industry
- AVBP
- INNV Medical/Nursing Services
- Sector
- AVBP
- INNV Health Care
- Exchange
- AVBP NYSE
- INNV Nasdaq
- Market Cap
- AVBP 980.3M
- INNV 817.8M
- IPO Year
- AVBP 2024
- INNV 2021
- Fundamental
- Price
- AVBP $27.81
- INNV $3.67
- Analyst Decision
- AVBP Strong Buy
- INNV Hold
- Analyst Count
- AVBP 5
- INNV 3
- Target Price
- AVBP $37.40
- INNV $6.00
- AVG Volume (30 Days)
- AVBP 140.3K
- INNV 56.0K
- Earning Date
- AVBP 02-10-2025
- INNV 02-04-2025
- Dividend Yield
- AVBP N/A
- INNV N/A
- EPS Growth
- AVBP N/A
- INNV N/A
- EPS
- AVBP N/A
- INNV N/A
- Revenue
- AVBP N/A
- INNV $786,512,000.00
- Revenue This Year
- AVBP N/A
- INNV $13.33
- Revenue Next Year
- AVBP N/A
- INNV $10.23
- P/E Ratio
- AVBP N/A
- INNV N/A
- Revenue Growth
- AVBP N/A
- INNV 12.46
- 52 Week Low
- AVBP $14.35
- INNV $3.50
- 52 Week High
- AVBP $36.37
- INNV $6.69
- Technical
- Relative Strength Index (RSI)
- AVBP 53.46
- INNV 44.76
- Support Level
- AVBP $25.90
- INNV $3.51
- Resistance Level
- AVBP $29.71
- INNV $4.00
- Average True Range (ATR)
- AVBP 1.49
- INNV 0.22
- MACD
- AVBP 0.25
- INNV 0.04
- Stochastic Oscillator
- AVBP 67.85
- INNV 42.86
About AVBP ARRIVENT BIOPHARMA INC
ArriVent BioPharma Inc is a clinical stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize team's deep drug development experience to maximize the potential of lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.
About INNV InnovAge Holding Corp.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.